1. Home
  2. TRX vs BMEA Comparison

TRX vs BMEA Comparison

Compare TRX & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • BMEA
  • Stock Information
  • Founded
  • TRX 1990
  • BMEA 2017
  • Country
  • TRX Canada
  • BMEA United States
  • Employees
  • TRX N/A
  • BMEA N/A
  • Industry
  • TRX
  • BMEA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRX
  • BMEA Health Care
  • Exchange
  • TRX Nasdaq
  • BMEA Nasdaq
  • Market Cap
  • TRX 95.9M
  • BMEA 103.5M
  • IPO Year
  • TRX N/A
  • BMEA 2021
  • Fundamental
  • Price
  • TRX $0.35
  • BMEA $1.83
  • Analyst Decision
  • TRX Strong Buy
  • BMEA Strong Buy
  • Analyst Count
  • TRX 1
  • BMEA 10
  • Target Price
  • TRX $1.10
  • BMEA $17.70
  • AVG Volume (30 Days)
  • TRX 514.5K
  • BMEA 683.1K
  • Earning Date
  • TRX 07-15-2025
  • BMEA 08-05-2025
  • Dividend Yield
  • TRX N/A
  • BMEA N/A
  • EPS Growth
  • TRX N/A
  • BMEA N/A
  • EPS
  • TRX N/A
  • BMEA N/A
  • Revenue
  • TRX $47,731,000.00
  • BMEA N/A
  • Revenue This Year
  • TRX $23.64
  • BMEA N/A
  • Revenue Next Year
  • TRX $51.77
  • BMEA N/A
  • P/E Ratio
  • TRX $327.04
  • BMEA N/A
  • Revenue Growth
  • TRX 29.98
  • BMEA N/A
  • 52 Week Low
  • TRX $0.27
  • BMEA $1.29
  • 52 Week High
  • TRX $0.43
  • BMEA $13.07
  • Technical
  • Relative Strength Index (RSI)
  • TRX 48.02
  • BMEA 56.62
  • Support Level
  • TRX $0.33
  • BMEA $1.51
  • Resistance Level
  • TRX $0.38
  • BMEA $1.86
  • Average True Range (ATR)
  • TRX 0.02
  • BMEA 0.10
  • MACD
  • TRX -0.00
  • BMEA 0.03
  • Stochastic Oscillator
  • TRX 35.40
  • BMEA 91.67

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.

Share on Social Networks: